← Open Payments lookup

CASEY WATSON: Open Payments

NPI 1164890281 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$875 in 16 payments from 12 companies in 2025. Trend: 2023 $491 · 2024 $620 · 2025 $875

Food & beverage: $875
CompanyPaymentsAmount
Alkermes, Inc.2$147
TMS NeuroHealth Centers Inc.1$139
ABBVIE INC.2$138
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$108
Axsome Therapeutics, Inc.1$107
Neurocrine BioSciences, Inc.1$103
Takeda Pharmaceuticals U.S.A., Inc.3$48
LivaNova USA, Inc.1$28
Otsuka America Pharmaceutical, Inc.1$15
E.R. Squibb & Sons, L.L.C.1$14

Products named: TMS NeuroHealth Centers Inc., VRAYLAR, LYBALVI, CAPLYTA, Auvelity, INGREZZA, TRINTELLIX, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR.

Industry payments across NC — which companies pay providers there.